Nimodipina Tecnilor (Nimodipine)

Nimodipine, the active ingredient in Nimodipina Tecnilor, is a calcium channel blocker presented as an oral formulation for oral use. It is used to prevent cerebral vasospasm after subarachnoid hemorrhage and may be employed off‑label as adjunctive therapy for hypertension. GNH USA supplies Nimodipina Tecnilor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nimodipine acts on the cerebral vasculature and systemic blood pressure regulation, making it useful in the following conditions: - Subarachnoid hemorrhage: prevents delayed cerebral vasospasm and reduces risk of ischemic neurological deficits. - Hypertension (off‑label): may assist in lowering blood pressure when standard agents are unsuitable. - Post‑surgical cerebral vasospasm: provides neurovascular protection after neurosurgical procedures.

Nimodipine may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Hypotension: transient drop in blood pressure. - Flushing: warmth and reddening of the skin. - Dizziness or light‑headedness. - Nausea or gastrointestinal discomfort. - Tachycardia: increased heart rate.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Myocardial infarction or cardiac ischemia. - Hepatic dysfunction or elevated liver enzymes. - Allergic reactions including rash, pruritus, or anaphylaxis. - Blood dyscrasias such as neutropenia or thrombocytopenia. - Seizures or altered mental status.

Before prescribing Nimodipina Tecnilor, clinicians should consider the following safety measures: - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution; assess liver enzymes regularly. - Concomitant antihypertensives: observe for additive blood‑pressure lowering effects. - Pregnancy: risk unknown; avoid unless benefits outweigh potential hazards. - Elderly patients: increased sensitivity to hypotensive effects; start at lower doses. - Store at room temperature: keep in the original container, protect from moisture and light.

Nimodipine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Potent vasodilators (e.g., nitroglycerin): may cause severe hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase plasma concentrations. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure lowering. - Diuretics: may enhance hypotensive response. - Anticoagulants/antiplatelets: monitor for bleeding if hypotension occurs.